Vincerx Pharma, Inc. (NASDAQ: VINC), relating to the proposed merger with Oqory, Inc. Under the terms of the agreement, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold 5%.
Vincerx Pharma, Inc. (NASDAQ: VINC), relating to the proposed merger with Oqory, Inc. Under the terms of the agreement, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold 5%.